May 24, 2018 / 12:30 PM / 3 months ago

BRIEF-Omeros Says Entered Into Settlement Agreement And Consent Judgment With Lupin Ltd and unit Lupin Pharmaceuticals - SEC Filing

May 24 (Reuters) - Lupin Ltd:

* OMEROS SAYS ENTERED INTO SETTLEMENT AGREEMENT AND CONSENT JUDGMENT WITH LUPIN LTD, SUBSIDIARY LUPIN PHARMACEUTICALS - SEC FILING

* OMEROS - AGREEMENT RESOLVES CO’S PATENT LITIGATION AGAINST LUPIN

* OMEROS CORP - LUPIN ACKNOWLEDGED & CONFIRMED VALIDITY OF EACH OF PATENTS LISTED IN ORANGE BOOK FOR OMIDRIA

* OMEROS CORP - PARTIES EXECUTED CONSENT JUDGMENT THAT WAS FILED WITH COURT FOR DISTRICT ON MAY 23, 2018

* OMEROS - LUPIN GRANTED LICENSE TO MAKE, SELL GENERIC VERSION OF OMIDRIA BETWEEN PERMITTED LAUNCH DATE & LATEST EXPIRATION OF CO’S U.S. PATENTS

* OMEROS CORP - LUPIN IS GRANTED NON-EXCLUSIVE, NON-SUBLICENSABLE WAIVER OF CO'S PEDIATRIC EXCLUSIVITY FOR OMIDRIA UNTIL AT LEAST APRIL 23, 2034 Source text: (bit.ly/2GKSJ0y) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below